期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

普伐他汀对高血压病人降压平滑性指数的影响 被引量：1

下载PDF
导出
摘要 目的观察调脂治疗对原发性高血压病人降压的平滑性指数(Smoothnessindex,SI)影响。方法选取110例诊断为原发性高血压的病人(血脂正常或略高LDL-C<3·1mmol/L)随机分为调脂降压治疗组和对照组,调脂降压治疗组采用普伐他汀20mg,1次/d,两组病人降压药物治疗无差异,药物剂量调整直至降压目标血压<140/90mmHg,所有病人均于治疗前及治疗后3月行动态血压检查,比较两组病人治疗前后降压值及降压平滑性指数变化。结果调脂降压治疗组治疗后血压(129·9±8·4/81·7±5·5)mmHg较对照组(131·3±9·8/85·7±7·5)mmHg无差异(P>0·05);调脂降压治疗组SI6·8较对照组3·2为高(P<0·05)。结论调脂治疗能够提高原发性高血压病人降压平滑性。
作者 滕志涛 唐蓉 陈焕章 郭丽蓉 马欲晓 黄蕊茵 吴荣 李卫华
机构地区 福建医科大学附属厦门第一医院高血压防治中心
出处 《高血压杂志》 CAS CSCD 北大核心 2006年第7期572-573,共2页 Chinese Journal of Hypertension
关键词 高血压 调脂治疗 降压平滑性
分类号 R544.1 [医药卫生—心血管疾病] R972.6 [医药卫生—药品]
  • 相关文献

参考文献6

  • 1Sever PS,Dahlof B,Poulter NR,et al.Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower than average cholesterol concentrations,in Anglo-Scandinavian cardiac outcomes trial-lipid lowering arm(ASCOT-LLA):a multicetrc randomized controlled trial[J].Lancet,2003,361:149-158.
  • 2Ferrier KE,Muhlmann MH,Baguet JP,et al.Intensive cholesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension[J].J Am Coll Cardiol,2002,39:1020-1025.
  • 3Zanchtti A.The role of ambulatory blood pressure monitoring in clinical practice[J].Am Hypertension,1997,10:1069-1073.
  • 4房振英,李亚非,张丽贞,韩威,李运乾.辛伐他汀对兔实验性动脉硬化引起的内皮功能失调的保护作用[J].中华心血管病杂志,1998,26(5):379-382. 被引量：8
  • 5陈月云,章辉,朱正才,王德国,张平洋.阿托伐他汀对不同血脂水平的高血压病患者血管内皮功能的影响[J].高血压杂志,2005,13(2):88-92. 被引量：19
  • 6MRC/BHF Heart Protection Study Collaborative Group[J].Lancet,2002,306:7-22.

二级参考文献11

  • 1Goode GK, Heagety AM. In vitro responese of human peripheral small arteries in hypercholesterolemia and effects of therapy[J].Circulation,1995,91:2898-2903.
  • 2Panza JA, Quyyumi AA, Brush JE, et al. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension[J].N Engl J Med,1990,323:22-27.
  • 3Sack FM, Pfetter MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patient with average cholesterol levels[J].N Engl J Med,1996,335:1001-1009.
  • 4Dobrucki W, Kalinowskil L. Statin-stimulated nitric oxide release from endothelium[J].Med Sci Monit,2001,7:622-627.
  • 5Kureishi Y, Luo Z, Shiojioma I, et al. The HMG-CoA reductase inhibitor sirastatin activates the protein kinase Akt and promotes angiogenesis in normocholesterolemic animals[J].Nat Med,2000,6:1004-1010.
  • 6Gloriose N, Troffa C, Filigheddu F, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia[J].Hypertension,1999,34:1281-1286.
  • 7Wassmann S, Laufs U, Baumer AT, et al. HMG-CoA reductase inhibitors improve endothelial dysfunction in normocholesterolemic hypertension via reduced production of reactive oxygen species[J].Hypertension,2001,137:1450-1457.
  • 8Hedblad B, Wildstraand J, Janzon L, et al. Low-dose metoprolol CR/XL and fluvastatin slow progression of carotid intima-media thickness[J].Circulation,2001,103:1721-1726.
  • 9Zhu B Q，J Cardiovasc Pharmacol，1992年，19卷，246页
  • 10苗懿德,苏琳.氨氯地平对老年高血压患者内皮功能及颈动脉内中膜的影响[J].高血压杂志,2002,10(5):418-420. 被引量：9

共引文献24

同被引文献15

  • 1Parati G,Pomidossi G,Albini F,et al. Relationship of 24-hour blood pressure mean and variability to severity of target-organdamage in hypertension[ J]. J Hypertens,1987,5( 1 ):93-98.
  • 2Rothwell PM, Howard SC, Dolan E, et al. Prognostic signifi- cance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension [ J ]. Lancet, 2010,375 (9718) :895 -905.
  • 3Ferrier KE, Muhlmann MH, Baguet JP, et al. Intensive cho- lesterol reduction lowers blood pressure and large artery stiffness in isolated systolic hypertension [ J ]. J Am Coil CardioI,2002,39(6) : 1 020 - 1 025.
  • 4Pelat M, Dessy C, Massion P, et al. Rosuvastatin decreases caveolin-1 and improves nitric oxide-dependent heart rate and blood pressure variability in apolipoprotein E-/- mice in vivo [ J ]. Circulation,2003,107 (19) :2 480 - 2 486.
  • 5Blacher J, Protogerou AD, Safar ME. Large artery stiffness and antihypertensive agents [ J ]. Curr Pharm Des, 2005,11 (25) :3 317 -3 326.
  • 6Danaolu Z, Ktilttirsay H, Kayikcio,lu M, et al. Effect of sta- tin therapy added to ACE-inhibitors on blood pressure con- trol and endothelial functions in normolipidemie hyperten- sive patients [ J ]. Anadolu Kardiyol Derg, 2003, 3 ( 4 ) : 331 - 337.
  • 7杨玫,何美,田州.福辛普利联合瑞舒伐他汀钙对高血压患者血压变异性的影响[J].实用临床医药杂志,2011,15(21):110-112. 被引量：15
  • 8李春艳,张华.高血压患者血压变异性与血脂异常的关系[J].实用心脑肺血管病杂志,2012,20(4):589-591. 被引量：38
  • 9李可莉,张丹参.阿托伐他汀对高血压患者血压变异性的影响[J].河北医药,2012,34(10):1492-1494. 被引量：4
  • 10李珂,葛正庆,周传堃,安闽生,李沂,杜荣生.阿托伐他汀钙对高血压病患者血压变异性影响研究[J].四川医学,2012,33(5):754-757. 被引量：13

引证文献1

二级引证文献15

高血压杂志
2006年 第7期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部